{"entity": "researcher", "timestamp": "2026-11-16T00:14:15.071Z", "family": "Stan", "given": "Radu V", "initials": "RV", "orcid": "0000-0003-2969-1725", "affiliations": ["Department of Pathology, Dartmouth College, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire 03756, USA."], "links": {"self": {"href": "https://publications-affiliated.scilifelab.se/researcher/c9bcc50aa299412c97dd5a63b7f1c407.json"}, "display": {"href": "https://publications-affiliated.scilifelab.se/researcher/c9bcc50aa299412c97dd5a63b7f1c407"}}, "publications": [{"entity": "publication", "iuid": "a29d886fc7ba4754bcb5dbc106c7ee29", "links": {"self": {"href": "https://publications-affiliated.scilifelab.se/publication/a29d886fc7ba4754bcb5dbc106c7ee29.json"}, "display": {"href": "https://publications-affiliated.scilifelab.se/publication/a29d886fc7ba4754bcb5dbc106c7ee29"}}, "title": "VEGFR2 pY949 signalling regulates adherens junction integrity and metastatic spread.", "authors": [{"family": "Li", "given": "Xiujuan", "initials": "X"}, {"family": "Padhan", "given": "Narendra", "initials": "N"}, {"family": "Sj\u00f6str\u00f6m", "given": "Elisabet O", "initials": "EO"}, {"family": "Roche", "given": "Francis P", "initials": "FP"}, {"family": "Testini", "given": "Chiara", "initials": "C"}, {"family": "Honkura", "given": "Naoki", "initials": "N"}, {"family": "S\u00e1inz-Jaspeado", "given": "Miguel", "initials": "M"}, {"family": "Gordon", "given": "Emma", "initials": "E"}, {"family": "Bentley", "given": "Katie", "initials": "K"}, {"family": "Philippides", "given": "Andrew", "initials": "A"}, {"family": "Tolmachev", "given": "Vladimir", "initials": "V"}, {"family": "Dejana", "given": "Elisabetta", "initials": "E"}, {"family": "Stan", "given": "Radu V", "initials": "RV", "orcid": "0000-0003-2969-1725", "researcher": {"href": "https://publications-affiliated.scilifelab.se/researcher/c9bcc50aa299412c97dd5a63b7f1c407.json"}}, {"family": "Vestweber", "given": "Dietmar", "initials": "D"}, {"family": "Ballmer-Hofer", "given": "Kurt", "initials": "K"}, {"family": "Betsholtz", "given": "Christer", "initials": "C"}, {"family": "Pietras", "given": "Kristian", "initials": "K"}, {"family": "Jansson", "given": "Leif", "initials": "L"}, {"family": "Claesson-Welsh", "given": "Lena", "initials": "L"}], "type": "journal article", "published": "2016-03-23", "journal": {"title": "Nat Commun", "issn": "2041-1723", "volume": "7", "issue": null, "pages": "11017", "issn-l": "2041-1723"}, "abstract": "The specific role of VEGFA-induced permeability and vascular leakage in physiology and pathology has remained unclear. Here we show that VEGFA-induced vascular leakage depends on signalling initiated via the VEGFR2 phosphosite Y949, regulating dynamic c-Src and VE-cadherin phosphorylation. Abolished Y949 signalling in the mouse mutant Vegfr2(Y949F/Y949F) leads to VEGFA-resistant endothelial adherens junctions and a block in molecular extravasation. Vessels in Vegfr2(Y949F/Y949F) mice remain sensitive to inflammatory cytokines, and vascular morphology, blood pressure and flow parameters are normal. Tumour-bearing Vegfr2(Y949F/Y949F) mice display reduced vascular leakage and oedema, improved response to chemotherapy and, importantly, reduced metastatic spread. The inflammatory infiltration in the tumour micro-environment is unaffected. Blocking VEGFA-induced disassembly of endothelial junctions, thereby suppressing tumour oedema and metastatic spread, may be preferable to full vascular suppression in the treatment of certain cancer forms.", "doi": "10.1038/ncomms11017", "pmid": "27005951", "labels": [], "xrefs": [{"db": "pmc", "key": "PMC4814575"}, {"db": "pii", "key": "ncomms11017"}], "notes": [], "created": "2018-12-05T09:28:32.132Z", "modified": "2026-09-23T07:25:17.072Z"}]}